Molecules:冬虫夏草菌丝培养提取物(Cs-4)对变应性鼻炎和哮喘模型鼠的抗炎作用

2020-09-25 AlexYang MedSci原创

变应性鼻炎和哮喘是呼吸道常见的慢性变应性疾病,伴有IgE介导的炎症和2 型辅助性T细胞、肥大细胞和嗜酸性粒细胞的参与。冬虫夏草是一种寄生在鳞翅目幼虫上的真菌。它被认为是一种促进健康的食物,也是治疗呼吸

变应性鼻炎和哮喘是呼吸道常见的慢性变应性疾病,伴有IgE介导的炎症和2 型辅助性T细胞、肥大细胞和嗜酸性粒细胞的参与。冬虫夏草是一种寄生在鳞翅目幼虫上的真菌。它被认为是一种促进健康的食物,也是治疗呼吸道疾病(如哮喘和肺部炎症)的最著名的草药之一。在近期发表在Molecules期刊上的一项研究中,来自香港中文大学等单位的科学家们研究证实了冬虫夏草菌丝培养水提物Cs-4对卵清蛋白(OVA)诱导的变应性鼻炎的抗炎作用,以及Cs-4对哮喘模型大鼠的平喘作用。

研究结果显示,Cs-4抑制了经ova致敏的小鼠的鼻症状。这种抑制作用与鼻液中IgE/OVA-IgE和白介素(IL)-4/IL-13水平降低相关。Cs-4也降低了辣椒素刺激大鼠的气道反应性,改善了抓挠行为。它还降低了支气管肺泡液中血浆IgE水平,以及IgE和嗜酸性粒细胞过氧化物酶水平。Cs-4完全抑制了大鼠肺组织中IL-4、IL-5、IL-13水平的升高。

Cs-4对气道反应性的影响

Cs-4对抓挠行为的影响

综上所述,他们的研究结果表明,Cs-4具有缓解变应性鼻炎和哮喘的超敏反应的潜力。

原始出处:

Chen J, Chan WM, Leung HY et al. Anti-Inflammatory Effects of a Cordyceps sinensis Mycelium Culture Extract (Cs-4) on Rodent Models of Allergic Rhinitis and Asthma. Molecules. 2020 Sep 4

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-09-28 刘煜

    阅读谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-09-26 ms3000001774039970

    xie

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-09-26 1205a032m39(暂无昵称)

    有价值的中医药研究

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-09-25 CHANGE

    梅斯里提供了很多疾病的模型计算公式,赞一个!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1677657, encodeId=e33d16e7657e8, content=<a href='/topic/show?id=34953103670' target=_blank style='color:#2F92EE;'>#冬虫夏草#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31036, encryptionId=34953103670, topicName=冬虫夏草)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Dec 28 20:53:27 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888832, encodeId=8d5f888832d1, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Sep 28 06:58:23 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323323, encodeId=3d3713233235b, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Sun Sep 27 10:53:27 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888487, encodeId=c1a688848eed, content=xie, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/386c9473e2f8416994ecd304498508c3/4e42c95ba2404ac4bad380a4d36007ed.jpg, createdBy=5f8c5409505, createdName=ms3000001774039970, createdTime=Sat Sep 26 10:34:55 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888443, encodeId=eb1f88844346, content=有价值的中医药研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd3a2173825, createdName=1205a032m39(暂无昵称), createdTime=Sat Sep 26 06:23:28 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047853, encodeId=8819104e85315, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 25 22:53:27 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888390, encodeId=4b9b888390a0, content=早日研究成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/7e96bbab0c5c420e8fe7846dcdd38c29/2b6be8f4b6284022a808d4f619b7aed6.jpg, createdBy=2aaa1602125, createdName=opzoro, createdTime=Fri Sep 25 21:07:54 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-09-25 opzoro

    早日研究成功

    0

相关资讯

Abivax将在两个会议上介绍其先导化合物ABX464的全新临床数据

Abivax是一家临床阶段的生物制药公司,利用免疫系统为患有炎症、自身免疫性疾病、病毒感染和癌症的患者开发新型治疗方法,近日宣布将在两个重要会议上公布ABX464治疗炎症性疾病和艾滋病的作用机制的研究数据。

Dent Mater J:含有表面预处理玻璃璃聚物(S-PRG)填料根管封闭剂的生物学评估

表面预处理的玻璃璃聚物(S-PRG)填料能够释放多种离子,如氟化物、硼酸盐和锶,以释放生物活性效应。研究将S-PRG填料融入根管封闭剂中(S-PRG sealer),随后评估S-PRG封闭剂的抗菌和抗炎效果,并与常规含氧化硅填料的封闭剂(silica sealer)相比较。

Int Immunopharmacol:MicroRNA-345-5p是实验过敏性鼻炎中的一个抗炎症因子

过敏性鼻炎(AR)是一种常见的慢性疾病,主要特征为鼻黏膜上的炎症。MicroRNA(miRNAs)在AR中的作用已经有所阐释,尤其是调控炎症响应中具有作用。最近,有研究人员在AR小鼠中探索了miR-3

诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线

诺华公司将以16亿美元收购IFM Therapeutics的IFM Tre部门。诺华将支付3.1亿美元的预付款,以获得IFM Tre的NLPR3拮抗剂组合,其中包括一个临床和两个临床前研究。

真的有抗炎饮食吗?

牙龈肿痛了、扁桃体肿痛了、不小心割破的伤口周围红肿了……这些都是大家很明显能感知到的急性炎症反应,还有一些慢性炎症反应,可能正在体内悄悄的进行着,我们自己毫不知情。那么炎症到底是怎么回事呢?炎症要不要全面抵抗呢?该怎么通过饮食来抵抗炎症呢?

Immunity:“一线”药物抗炎的背后

糖皮质激素(GC)具有抗炎、抗过敏、抗毒、抗休克等作用,是临床上的常用药物,更是多种急、慢性炎症治疗的一线用药。但是,其抗炎作用背后的机制仍未明确。